UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Unitil
UTL
$980M
| $5.22M | ﹤0.01% |
96,243
+75,997
| +375% | +$4.41M |
|
3802
Limbach Holdings
LMB
$581M
| $5.21M | ﹤0.01% |
60,930
+45,948
| +307% | +$4.05M |
|
3803
PUT
Domino's
DPZ
$11.6B
| $5.21M | ﹤0.01% |
12,400
| – | – |
|
3804
Altimmune
ALT
$599M
| $5.19M | ﹤0.01% |
719,555
+437,100
| +155% | +$3.34M |
|
3805
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
| $5.18M | ﹤0.01% |
242,271
-144,579
| -37% | -$3.23M |
|
3806
Aspen Aerogels
ASPN
$518M
| $5.18M | ﹤0.01% |
435,843
+304,592
| +232% | +$5.19M |
|
3807
Triumph Financial Inc
TFIN
$1.82B
| $5.17M | ﹤0.01% |
56,847
+31,908
| +128% | +$2.97M |
|
3808
BlueLinx
BXC
$706M
| $5.16M | ﹤0.01% |
50,545
+44,147
| +690% | +$5.06M |
|
3809
Novanta
NOVT
$6.29B
| $5.16M | ﹤0.01% |
33,799
+11,649
| +53% | +$1.97M |
|
3810
Invesco Trust Investment Grade Municipals
VGM
$564M
| $5.16M | ﹤0.01% |
511,076
+19,189
| +4% | +$197K |
|
3811
PUT
Lyft
LYFT
$6.63B
| $5.16M | ﹤0.01% |
400,000
-450,000
| -53% | -$6.67M |
|
|
JNPR
3812
PUT
DELISTED
Juniper Networks
JNPR
| $5.15M | ﹤0.01% |
137,600
+82,300
| +149% | +$3.11M |
|
3813
MasterBrand
MBC
$1.91B
| $5.15M | ﹤0.01% |
352,267
+188,472
| +115% | +$3.21M |
|
3814
GigaCloud Technology
GCT
$1.9B
| $5.14M | ﹤0.01% |
277,690
+257,997
| +1,310% | +$5.97M |
|
3815
Prothena Corp
PRTA
$450M
| $5.14M | ﹤0.01% |
371,287
+308,781
| +494% | +$4.87M |
|
3816
XPEL
XPEL
$1.38B
| $5.12M | ﹤0.01% |
128,179
+118,570
| +1,234% | +$5.06M |
|
3817
Protagonist Therapeutics
PTGX
$9.44B
| $5.12M | ﹤0.01% |
132,609
+53,810
| +68% | +$2.35M |
|
3818
CALL
Global E Online
GLBE
$7.11B
| $5.11M | ﹤0.01% |
93,800
-157,377
| -63% | -$7.12M |
|
3819
Grupo Aeroportuario del Pacifico
PAC
$13.3B
| $5.11M | ﹤0.01% |
29,202
+27,624
| +1,751% | +$4.96M |
|
3820
Vanguard Russell 2000 Value ETF
VTWV
$1.31B
| $5.11M | ﹤0.01% |
35,333
+452
| +1% | +$68K |
|
|
BRY
3821
DELISTED
Berry Corp
BRY
| $5.1M | ﹤0.01% |
1,235,914
+1,024,921
| +486% | +$4.73M |
|
3822
Greif
GEF
$5.04B
| $5.1M | ﹤0.01% |
83,489
+56,550
| +210% | +$3.69M |
|
3823
iShares MSCI France ETF
EWQ
$345M
| $5.1M | ﹤0.01% |
142,006
+69,198
| +95% | +$2.58M |
|
|
DMC
3824
Del Monte Corp
DMC
$1.45B
| $5.09M | ﹤0.01% |
153,160
+97,758
| +176% | +$3.14M |
|
3825
PUT
GSK
GSK
$106B
| $5.07M | ﹤0.01% |
150,000
+100,100
| +201% | +$3.6M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.